Depressive Disorder, Major: all 2,805 studies
Page 26 of 29. Open to participants first (565), then studies with results posted, then the rest; newest registration first within each.
- Validating PROMIS Instruments in DepressionCompletedNCT00784199
- Antidepressant Incomplete Response DepressionCompletedNCT00782964
- Effect of Quetiapine XR on Sleep in Patients With Major Depression, as Compared With MirtazapineCompletedNCT00782405Phase 3
- AZD6765 Severe Major Depressive Disorder (MDD) IVCompletedNCT00781742Phase 2
- Using Neuroimaging to Investigate Major Depressive DisorderCompletedNCT00781677
- Magnetic Seizure Therapy (MST) for Treatment Resistant Major DepressionCompletedNCT00770783Phase 3
- Efficacy and Safety of Lu AA34893 in Patients With Major Depressive DisorderTerminatedNCT00766870Phase 2
- Linköping University Relational and Interpersonal Psychotherapy ProjectTerminatedNCT00763594Phase 2
- A Study of Transcranial Direct Current Stimulation (tDCS) to Treat DepressionCompletedNCT00763230Phase 2/3
- Electroencephalography (EEG) Biomarkers of Response in DepressionCompletedNCT00759122Phase 4
- Quetiapine in the Treatment of Psychotic Depression - a Pilot StudyCompletedNCT00751504Phase 3
- T- BOOM Teens--Building Options and Opportunities for MomsCompletedNCT00745537Not applicable
- Stress Generation and Recurrent Depression: The Role of Differential Treatment ResponseCompletedNCT00745017Phase 1
- Patient Dimensions as Predictors of Varied Treatment Responses and Outcomes in Patients With Major DepressionCompletedNCT00744406Phase 2
- Efficacy of SEROQUEL in Selective Serotonin Reuptake Inhibitors (SSRI)-Resistant Major Depressive DisorderCompletedNCT00733668Phase 2
- Creatine Augmentation Treatment in Major Depressive Disorder SubjectsCompletedNCT00729755Not applicable
- Quetiapine Extended Release (XR) for the Treatment of Menopausal DepressionCompletedNCT00723970Phase 4
- Fluoxetine vs. Brief Psychotherapy for Major DepressionCompletedNCT00714779Not applicable
- Exploring a Potential Blood Test to Diagnose Major Depressive DisorderCompletedNCT00705185
- Treatment-Resistant Depression, Hippocampus Atrophy and Serotonin Genetic PolymorphismCompletedNCT00704860Phase 4
- The WORKER Study: Escitalopram and Telephone-based Cognitive Behaviour Therapy (CBT) for Depressed Working PeopleCompletedNCT00702598Not applicable
- p11 Protein Levels in Patients With Major Depressive Disorder Treated With CitalopramCompletedNCT00697268
- The Effect of Exercise on Depressive Symptoms in Unmedicated PatientsTerminatedNCT00695552Not applicable
- International Study to Predict Optimised Treatment - in DepressionStatus unknownNCT00693849Phase 4
- TC-5214 as add-on the Treatment of Major Depressive DisorderCompletedNCT00692445Phase 2
- Genetics of Symptomatology and Treatment Response in Psychotic Major DepressionCompletedNCT00691535
- Quetiapine in Co-Morbid Depressive and Anxiety DisordersCompletedNCT00688818Not applicable
- A Study of Quetiapine Fumarate Sustained Release in Major Depression With Comorbid Fibromyalgia SyndromeCompletedNCT00675896Phase 4
- Pipamperone/Citalopram (PipCit)Versus Citalopram in the Treatment of Major Depressive Disorder(MDD)CompletedNCT00672659Phase 2
- Transcranial Direct Current Stimulation (tDCS) in Treatment-resistant DepressionCompletedNCT00667680Phase 2
- Relapse Prevention With Escitalopram or Nortriptyline Following Electro-Convulsive Treatment (DUAG-7)TerminatedNCT00660062Phase 4
- Efficacy and Safety of DOV 21,947 in the Treatment of Major Depressive DisorderTerminatedNCT00659347Phase 2
- Prevention of Depression in HIV/HCV Co-infected Substance Abuse PatientsTerminatedNCT00655226Not applicable
- Efficacy Study of Escitalopram for Depression in Patients With DiabetesStatus unknownNCT00650897Phase 4
- Ketamine Frequency Treatment for Major Depressive DisorderWithdrawnNCT00646087Phase 4
- A Comparison of Sertraline Versus Venlafaxine XR in the Treatment of Major DepressionCompletedNCT00644982Phase 4
- Antidepressant Therapy for Bipolar II Major DepressionCompletedNCT00641927Phase 4
- A Comparison of Sertraline-reboxetine Combination Therapy Versus Sertraline or Reboxetine Monotherapy in the Treatment of Major Depression.CompletedNCT00636246Phase 2
- An Eight-week Study of Saredutant and Paroxetine as Combination Treatment for Major Depressive DisorderCompletedNCT00629551Phase 3
- Brain Mechanisms and Targeting Insomnia in Major DepressionStatus unknownNCT00628914Phase 4
- Randomised Controlled Trial of Electroconvulsive Therapy (ECT) in Relapse Prevention of DepressionCompletedNCT00627887Phase 4
- Safety and Effectiveness Study of BCI-540 Versus Placebo in the Treatment of Major Depressive Disorder With Concomitant AnxietyCompletedNCT00621270Phase 2
- Behavioral Insomnia Therapy For Those With Insomnia and DepressionStatus unknownNCT00620789Not applicable
- Interpersonal Psychotherapy for Depressed Adolescents and ParentsCompletedNCT00619411Phase 1
- Omega-3 Fatty Acids for Major Depressive Disorder During PregnancyCompletedNCT00618865Not applicable
- Duloxetine for the Treatment of Postpartum DepressionWithdrawnNCT00617045Not applicable
- Does Sleep Quality Change After Switch From Wellbutrin SR to Wellbutrin XL in Patients With Major Depressive Disorder?CompletedNCT00616915Phase 1
- Effect of Quetiapine on Sleep Architecture in Bipolar Depression and Major Depressive DisorderCompletedNCT00616889
- Advanced MRI in Major DepressionCompletedNCT00613912
- Brief Behavioral Therapy for Insomnia (bBT-I) for Depressed Outpatients With Refractory InsomniaCompletedNCT00610259Phase 2/3
- Brain Imaging of Psychotherapy for DepressionCompletedNCT00609453Not applicable
- Dose-finding Study With Lu AA24530 in Major Depressive DisorderCompletedNCT00599911Phase 2
- Escitalopram Treatment of Major Depression in Patients With Temporal Lobe EpilepsyCompletedNCT00595699Phase 4
- Flexible Dose Titration Add-on Study to Treat Major Depressive DisorderCompletedNCT00593879Phase 2
- A Safety, Efficacy and Tolerability Study of SEP-225289CompletedNCT00584974Phase 2
- Clinical and Biological Characteristics of Psychotic DepressionCompletedNCT00576095
- Effect of Intranasal Insulin on Depressive Symptoms in Major Depressive DisorderCompletedNCT00570050Phase 3
- A Study of GW856553X For the Treatment of DepressionTerminatedNCT00569062Phase 2
- Optimal Duration of Olanzapine Add-on Therapy in Major DepressionWithdrawnNCT00568672Phase 3
- A Safety and Effectiveness Study of JNJ-18038683 in Patients With Moderate to Severe DepressionCompletedNCT00566202Phase 2
- Biochemical Brain Changes Correlated With The Antidepressant Effect Of Thyroid HormonesCompletedNCT00562367Not applicable
- Multi-Country Observational Study to Collect the Frequency of Sexual Dysfunction With Antidepressant Treatment, Either With SSRIs or Duals at 8 Weeks and 6 MonthsCompletedNCT00561509
- Patient Tolerability Study of GSK163090CompletedNCT00559299Phase 1
- SA4503 8-Week Study in Major Depressive Disorder (MDD)CompletedNCT00551109Phase 2
- Continuation Ketamine in Major DepressionCompletedNCT00548964Phase 1
- Randomized Trial of Psychotherapy for Persistently Depressed Primary Care PatientsCompletedNCT00541957Phase 1
- Pivotal Trial (D02) of Vagus Nerve Stimulation (VNS) for Treatment-Resistant Depression (TRD)CompletedNCT00533832Not applicable
- An Open Trial of Duloxetine on Comorbid Major Depression and Chronic HeadacheCompletedNCT00531895Phase 4
- An Eight-week Study of Saredutant and Escitalopram as Combination Treatment for Major Depressive DisorderCompletedNCT00531622Phase 3
- Do Antidepressants Induce Metabolic Syndromes METADAP StudyCompletedNCT00526383Not applicable
- Study of Adolescence and DepressionCompletedNCT00523081Phase 3
- Duloxetine for Perimenopausal DepressionCompletedNCT00517985Phase 4
- Childhood Adversity, Genetic Polymorphisms and Stress in First Onset Major DepressionCompletedNCT00517764Not applicable
- Omega-3 Fatty Acids for Treating Adults With Major DepressionCompletedNCT00517036Phase 3
- Antidepressant Effect of Theta-Burst rTMSStatus unknownNCT00515658Phase 2
- Placebo-Controlled Study of ONO-2333Ms in Patients With Recurrent Major Depressive DisorderCompletedNCT00514865Phase 2
- Cimicoxib for the Treatment of Major Depression (SECIM)CompletedNCT00510822Phase 2
- Smoking Cessation for Depressed SmokersActive, not recruitingNCT00494728Phase 1/2
- Duloxetine Versus Paroxetine for Major DepressionCompletedNCT00489775Phase 3
- eCare for Moods: An Internet-based Management ProgramCompletedNCT00485420Not applicable
- Yoga in Unipolar and Bipolar DisordersCompletedNCT00482482Not applicable
- Lilly's Emotional and Physical Symptoms of Depression Study (LEAPS)CompletedNCT00479726Phase 4
- Efficacy, Safety and Tolerability of Agomelatine in the Prevention of Relapse of Major Depressive DisorderCompletedNCT00467402Phase 3
- A Controlled Study to Assess the Effectiveness of Aerobic Exercise as an Augmentation Therapy for Inpatients With Major Depressive DisorderStatus unknownNCT00464048Not applicable
- A Placebo- and Paroxetine-controlled Study of the Efficacy, Safety and Tolerability of Agomelatine (25 or 50 mg) in the Treatment of Major Depressive Disorder (MDD)CompletedNCT00463242Phase 3
- Attachment Security as Mediator and Moderator of Outcome in Major DepressionCompletedNCT00461279Not applicable
- Evaluation of the Deep TMS H-Coil in the Treatment of Major Depression- Augmentation of Antidepressant MedicationCompletedNCT00460902Phase 1/2
- Study Evaluating the Potential of DVS SR to Inhibit the CYP2D6 PathwayCompletedNCT00456898Phase 1
- Study Evaluating DVS-233 for Treatment of Outpatients With Major Depressive DisorderCompletedNCT00452595Phase 3
- St. John's Wort And Kava In The Treatment Of Major Depressive Disorder With Comorbid AnxietyCompletedNCT00451516Phase 2
- The Effect of Agomelatine or Fluoxentine on Heart Rate Variability in Patients With Major Depressive DisorderWithdrawnNCT00451490Not applicable
- A Efficacy Study of PRX-00023 in Patients With Major Depressive DisorderCompletedNCT00448292Phase 2
- Effects of Ghrelin on the Sleep-EEG and Nocturnal Secretion of HormonesCompletedNCT00447512Not applicable
- Safety and Antidepressant Effects of Rellidep in Major Depressive DisorderCompletedNCT00446719Phase 2/3
- Evaluation of Deep Transcranial Magnetic Stimulation (TMS) H-Coil in the Treatment of Major DepressionCompletedNCT00445237Phase 1
- Escitalopram and Sleep Architecture in Patients With Major Depressive DisorderStatus unknownNCT00442481Phase 4
- Study Evalutating the Pharmacokinetics (PK) and Safety of a Single Dose of Desvenlafaxine Sustained Release (DVS SR)CompletedNCT00440427Phase 1
- A Study of Eszopiclone Co-administered With Venlafaxine in Subjects With Major Depressive Disorder and InsomniaCompletedNCT00435279Phase 3
- Screening for Mental Health Concerns for at-Risk Community Living Chinese SeniorsStatus unknownNCT00433238Phase 1
- Efficacy and Safety of SR58611A co-Administered With Escitalopram in Adults With Major Depressive DisorderCompletedNCT00432614Phase 3